US average mortgage rates fall; 30-year at 4.28 percent

WASHINGTON — U.S. long-term mortgage rates fell this week, giving an incentive to potential buyers as the spring homebuying season opens.

Mortgage buyer Freddie Mac said Thursday the average rate on the 30-year, fixed-rate mortgage declined to 4.28 percent from 4.31 percent the previous week.

Mortgage rates have fallen substantially since the beginning of the year, after climbing for much of 2018 and peaking at nearly 5 percent in early November. The average rate on the benchmark 30-year loan stood at 4.45 percent a year ago.

The average rate this week for 15-year, fixed-rate loans slipped to 3.71 percent from 3.76 percent a week earlier.

With economic growth showing signs of slowing in the U.S. and abroad, interest rates have eased. Reflecting dimmer expectations for growth, the Federal Reserve left its key interest rate unchanged Wednesday. The Fed kept the rate — which can influence mortgage loans as well as credit cards, home equity lines of credit and more — in a range of 2.25 percent to 2.5 percent.

The lower home-lending rates, combined with continued moderation of home prices, should enhance affordability for homebuyers as the season begins, Freddie Mac chief economist Sam Khater said.

To calculate average mortgage rates, Freddie Mac surveys lenders across the country between Monday and Wednesday each week.

The average doesn't include extra fees, known as points, which most borrowers must pay to get the lowest rates.

The average fee on 30-year fixed-rate mortgages was unchanged this week at 0.4 point. The fee on 15-year mortgages also held steady at 0.4 point.

The average rate for five-year adjustable-rate mortgages was unchanged at 3.84 percent. The fee remained at 0.3 point.

Must Read

Fidel Castro thanks Cuba, criticizes Obama, on 90th birthday

Aug 14, 2016

Fidel Castro thanked Cubans for their well-wishes on his 90th birthday and criticized President Barack Obama in a lengthy letter published in state media

Global stocks dip ahead of release of Fed minutes

Aug 17, 2016

Global stocks and the price of oil dipped Wednesday as investors awaited the release of the minutes to the Federal Reserve's latest meeting for hints on when the next interest rate increase might come

Patent for J&J's Remicade invalidated, cheaper version looms

Aug 17, 2016

A cheaper version of Johnson & Johnson's top-selling drug, the rheumatoid arthritis treatment Remicade, could be available in the U.S. two years early after a federal judge ruled a key patent on the drug invalid

Search

Obserworld delivers the most accurate and up-to-date world news for the global audience with a thorough research and in-depth interviews. Discover the world through Obserworld.

Contact us: sales[at]obserworld.com